[Polymorphonuclear neutrophils in myocardial ischemia and reperfusion injury. Influence of coronary intervention?]

Andreas Link1, Holger Schwerdt, Benno Hennen

  • 1Medizinische Klinik und Poliklinik, Innere Medizin III Universitätskliniken des Saarlandes, 66421 Homburg/Saar, Germany. andreas.link@telemed.de

Zeitschrift Fur Kardiologie
|September 1, 2004
PubMed
Abstract

Insights

Early and short coronary interventions, especially with stenting, reduce polymorphonuclear neutrophil (PMN) activation in myocardial infarction patients. This attenuation of PMN response may explain better outcomes with stenting and timely procedures.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Interventional Cardiology

Background:

  • Polymorphonuclear neutrophils (PMNs) play a role in myocardial ischemia and reperfusion injury.
  • Understanding PMN inflammatory responses is crucial for optimizing acute myocardial infarction (AMI) treatment.

Purpose of the Study:

  • To investigate how ischemia duration, coronary intervention type (PTCA vs. PTCA plus stenting), and procedure length affect PMN inflammatory responses in AMI patients.

Main Methods:

  • Measured neutrophil beta-2-integrin Mac-1 and L-selectin in 20 AMI patients before and after percutaneous transluminal coronary angioplasty (PTCA) or PTCA plus stenting.
  • Analyzed changes based on intervention timing (early vs. delayed) and procedure duration.

Main Results:

  • PTCA alone, particularly when delayed or prolonged, significantly increased Mac-1 expression and L-selectin shedding.
  • PTCA plus stenting and early, short interventions attenuated these PMN activation markers.
  • Early intervention prevented the significant increase in Mac-1 observed after delayed procedures.

Conclusions:

  • PMN activation is significantly reduced by early, short coronary interventions and by the use of stenting.
  • Attenuated PMN activation likely contributes to the improved clinical outcomes observed with stenting and early intervention compared to delayed conventional PTCA.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...